Merus Eulerpool Vijesti

Merus Aktie News

Merus prate mnogi novinari i investitori širom svijeta. Najnovije Merus vijesti prikupljamo ovdje.

• 7. travnja ·

  SeekingAlpha
  Merus: Riding The Bispecific Wave In Oncology
• 27. ožujka ·

  SeekingAlpha
  Franklin Biotechnology Discovery Fund Q4 2024 Commentary
• 20. siječnja ·

  SeekingAlpha
  Time To Upgrade Merus N.V. To A 'Buy' After The Recent Selloff
• 17. siječnja ·

  Yahoo
  Merus N.V. (MRUS): The Biotech Stock with Biggest Upside Potential
• 7. siječnja ·

  Yahoo
  Jim Cramer Says Merus (MRUS) Still ‘Very Speculative’
• 17. prosinca ·

  SeekingAlpha
  Harbor Health Care ETF Q3 2024 Commentary
• 10. prosinca ·

  Yahoo
  Merus (MRUS): FDA Approval and Speculative Future in Cancer Therapy
• 7. prosinca ·

  Yahoo
  Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC
• 4. prosinca ·

  Yahoo
  Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study
• 4. prosinca ·

  Yahoo
  Merus price target lowered to $109 from $111 at Guggenheim